Inhaled Adenovirus-Vectored SARS-CoV-2 Vaccine (AZD1222/ChAdOx1-nCov-19) Induces Long-Lasting, Polyfunctional T Cell Responses in Human Blood and Lung: A Single-Centre, Open-Label, Phase I Clinical Trial
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
SARS-CoV-2 and COVID-19 Research
COVID-19 Clinical Research Studies
Immune responses and vaccinations
Publication details
- Journal / source
- SSRN Electronic Journal
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Preprint